Deutsche Biotech Innovativ Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Public

  • Employees
  • 1

Employees

  • Stock Symbol
  • DBI

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $1.24
  • (As of Monday Closing)

Deutsche Biotech Innovativ General Information

Description

Deutsche Biotech Innovativ AG operates as a biotechnology company in Germany. The group invests in biotechnology companies that pursue a research and development approach and develop drug candidates with a high degree of selling proposition.

Contact Information

Website
www.dbi-ag.de
Formerly Known As
Venetus Beteiligungen
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Neuendorfstrasse 15a
  • 16761 Hennigsdorf
  • Germany
+49 03302
Primary Industry
Holding Companies
Other Industries
Other Financial Services
Stock Exchange
MUN
Corporate Office
  • Neuendorfstrasse 15a
  • 16761 Hennigsdorf
  • Germany
+49 03302

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Deutsche Biotech Innovativ Stock Performance

As of 30-Sep-2024, Deutsche Biotech Innovativ’s stock price is $1.24. Its current market cap is $1.48M with 947K shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.24 $1.22 $1.17 - $19.52 $1.48M 947K 423.33 -$1.26

Deutsche Biotech Innovativ Financials Summary

As of 31-Dec-2025, Deutsche Biotech Innovativ has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 31-Dec-2025 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,059 8,202
Revenue 0 0 0 0
EBITDA 67 67 (975) (53)
Net Income (42) (42) (1,075) (1,181)
Total Assets 2,012 2,012 1,788 1,774
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Deutsche Biotech Innovativ Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Deutsche Biotech Innovativ‘s full profile, request access.

Request a free trial

Deutsche Biotech Innovativ Patents

Deutsche Biotech Innovativ Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10793626-B2 Adrenomedullin binder for use in therapy of cancer Active 20-Dec-2013
US-20160319007-A1 Adrenomedullin binder for use in therapy of cancer Active 20-Dec-2013

Deutsche Biotech Innovativ Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Deutsche Biotech Innovativ Investments & Acquisitions (4)

Deutsche Biotech Innovativ’s most recent deal was a Early Stage VC with Amidation Company for . The deal was made on 24-Jan-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Amidation Company 24-Jan-2022 Early Stage VC Drug Discovery
Belano Medical 31-Aug-2020 Later Stage VC Drug Discovery
Adrenomed 17-Jun-2020 Later Stage VC Drug Discovery
AngioBiomed 01-Feb-2015 Merger/Acquisition Drug Discovery
To view Deutsche Biotech Innovativ’s complete investments and acquisitions history, request access »

Deutsche Biotech Innovativ ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Deutsche Biotech Innovativ’s complete esg history, request access »

Deutsche Biotech Innovativ Exits (3)

Deutsche Biotech Innovativ’s most recent exit was on 24-Jan-2022 from Amidation Company. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Amidation Company 24-Jan-2022 Completed
  • 2 buyers
Belano Medical 31-Aug-2020 Completed
  • 2 buyers
AngioBiomed 01-Feb-2015 Merger/Acquisition Completed
To view Deutsche Biotech Innovativ’s complete exits history, request access »

Deutsche Biotech Innovativ FAQs

  • When was Deutsche Biotech Innovativ founded?

    Deutsche Biotech Innovativ was founded in 2009.

  • Where is Deutsche Biotech Innovativ headquartered?

    Deutsche Biotech Innovativ is headquartered in Hennigsdorf, Germany.

  • What is the size of Deutsche Biotech Innovativ?

    Deutsche Biotech Innovativ has 1 total employees.

  • What industry is Deutsche Biotech Innovativ in?

    Deutsche Biotech Innovativ’s primary industry is Holding Companies.

  • Is Deutsche Biotech Innovativ a private or public company?

    Deutsche Biotech Innovativ is a Public company.

  • What is Deutsche Biotech Innovativ’s stock symbol?

    The ticker symbol for Deutsche Biotech Innovativ is DBI.

  • What is the current stock price of Deutsche Biotech Innovativ?

    As of 30-Sep-2024 the stock price of Deutsche Biotech Innovativ is $1.24.

  • What is the current market cap of Deutsche Biotech Innovativ?

    The current market capitalization of Deutsche Biotech Innovativ is $1.48M.

  • What is Deutsche Biotech Innovativ’s annual earnings per share (EPS)?

    Deutsche Biotech Innovativ’s EPS for 12 months was -$1.26.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process